A Multicenter, Randomized, Double-blind, and Parallel Groups, Placebo-controlled Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain.
The purpose of this study is to study the efficacy of intravenous administration of ibuprofen compared to placebo in patients with postoperative pain and evaluate its tolerability and safety profile.
100 项与 Biomendi SAU 相关的临床结果
0 项与 Biomendi SAU 相关的专利（医药）
100 项与 Biomendi SAU 相关的药物交易
100 项与 Biomendi SAU 相关的转化医学
